Holen Sie sich die Stockscreener-App
63.76
0.38%
0.24
Schlusskurs vom Vortag:
$63.52
Offen:
$63.14
24-Stunden-Volumen:
251.81K
Relative Volume:
0.59
Marktkapitalisierung:
$1.90B
Einnahmen:
$229.58M
Nettoeinkommen (Verlust:
$-43.74M
KGV:
-42.94
EPS:
-1.4848
Netto-Cashflow:
$-42.61M
1W Leistung:
+7.74%
1M Leistung:
-5.90%
6M Leistung:
-2.09%
1J Leistung:
+28.57%
1-Tages-Spanne:
$62.85
$64.94
1-Wochen-Bereich:
$57.88
$65.61
52-Wochen-Spanne:
$47.00
$97.59
Establishment Labs Holdings Inc Stock (ESTA) Company Profile
Firmenname
Establishment Labs Holdings Inc
Sektor
Branche
Telefon
50624342400
Adresse
BUILDING B15 AND 25 COYOL FREE ZONE, ALAJUELA
Compare ESTA vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ESTA
Establishment Labs Holdings Inc
|
63.76 | 1.90B | 229.58M | -43.74M | -42.61M | -1.4848 |
ABT
Abbott Laboratories
|
103.70 | 179.44B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.41 | 122.04B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.19 | 117.83B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.67 | 66.19B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.04 | 51.32B | 6.30B | 1.07B | 1.09B | 1.8406 |
Establishment Labs Holdings Inc Stock (ESTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-10-15 | Eingeleitet | Stifel | Buy |
| 2026-08-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-08-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-05-16 | Eingeleitet | BTIG Research | Buy |
| 2025-05-14 | Hochstufung | Needham | Hold → Buy |
| 2025-04-14 | Eingeleitet | Needham | Hold |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-08-31 | Eingeleitet | JP Morgan | Overweight |
| 2023-06-29 | Eingeleitet | Citigroup | Buy |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-08-24 | Eingeleitet | B. Riley Securities | Buy |
| 2020-08-27 | Eingeleitet | UBS | Buy |
| 2020-05-14 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2019-06-28 | Eingeleitet | Wells Fargo | Outperform |
| 2019-06-07 | Eingeleitet | Stephens | Overweight |
Alle ansehen
Establishment Labs Holdings Inc Aktie (ESTA) Neueste Nachrichten
Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Should You Buy? - Zacks Investment Research
Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29 - FinancialContent
Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29 - Business Wire
Establishment Labs stock closed at USD 59.18 on October 16, down 3.55 percent - ad-hoc-news.de
Stifel sets USD 85.00 target for Establishment Labs stock, 39.07 percent above price - ad-hoc-news.de
Establishment Labs stock rating reiterated at Buy by TD Cowen ahead of FDA decision - Investing.com
Stifel Nicolaus Initiates Coverage on Establishment Labs With Buy Rating, $85 Price Target - Yahoo Finance
Establishment Labs Extends NuSil Silicone Supply Agreement to 2031, Adds Renewal Options - TradingView
Establishment Labs (ESTA) amends silicone supply deal with up to five annual renewals - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Stifel initiates Establishment Labs stock with buy rating, $85 target - Investing.com
Establishment Labs Holdings Inc (ESTA) Shares Fall 5.2% -- What GF Score of 76 Tells Investors - GuruFocus
Form 4 Establishment Labs Holdings Inc: Bryan Slotkin (Director) For: 30 September - Investing.com Nigeria
Form 4 Establishment Labs Holdings Inc: Nicholas Sheridan Lewin (Director) For: 30 September By Investing.com - Investing.com South Africa
Form 4 Establishment Labs Holdings Inc: Nicholas Sheridan Lewin (Director) For: 30 September - Investing.com UK
Form 4 Establishment Labs Holdings Inc: Ann Custin (Director) For: 30 September - Investing.com Nigeria
Establishment Labs Holdings Inc (ESTA) Stock Down 5.1% -- Now Un - GuruFocus
Establishment Labs Holdings Inc. (ESTA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Analysts Are Bullish on These Healthcare Stocks: GE Healthcare Technologies Inc (GEHC), Establishment Labs Holdings (ESTA) - The Globe and Mail
Establishment Labs Holdings (ESTA) Wins Expanded FDA Clearance, Is The Stock Still A Bargain? - Yahoo Finance
Establishment Labs Hldgs Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
Establishment Labs (ESTA) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $ESTA - MarketBeat
Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants® - Business Wire
Establishment Labs Holdings Inc. (ESTA) Slips to $63.49 as Shares Test Mid-Range SupportAscending Triangle - siam.in
Liquidity Mapping Around (ESTA) Price Events - Stock Traders Daily
Establishment Labs Holdings (NASDAQ:ESTA) In Focus After Clinical Data Presentation And Product Line Extensions - Kalkine Media
Establishment Labs stock falls 3.22 percent after Q2 loss - AD HOC NEWS
A Look at Establishment Labs Holdings Inc (ESTA) After 3.2% Decl - GuruFocus
Is Establishment Labs’ (ESTA) Profitability Inflection the Ultimate Buying Opportunity? - Insider Monkey
Is Establishment Labs’ (ESTA) Profitability Inflection the Ultimate Buying Opportunity? - insidermonkey.com
Is Establishment Labs’ (ESTA) Profitability Inflection the Ultimate Buying Opportunity? - Yahoo Finance
Establishment Labs Holdings Inc (ESTA) Shares Fall 3.5% -- GF Va - GuruFocus
Establishment Labs presents clinical data, expands product lines - Investing.com
New sizes could let more patients consider less invasive breast augmentation - Stock Titan
Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11 - Business Wire
ESTA: Establishment Labs Holdings Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants - Yahoo Finance
Establishment Labs stock holds steady after latest earnings and regulatory update - AD HOC NEWS
A Look at Establishment Labs Holdings Inc (ESTA) After 4.3% Decl - GuruFocus
(ESTA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Establishment Labs: Procedure Economics Strengthens The Bull Case (NASDAQ:ESTA) - Seeking Alpha
ESTA stock reacts to analyst backing and valuation debate - ad-hoc-news.de
Taylor Harris Named to Establishment Labs’ Board of Directors - Medical Product Outsourcing
Analysts Offer Insights on Healthcare Companies: McKesson (MCK), uniQure (QURE) and Establishment Labs Holdings (ESTA) - theglobeandmail.com
A Look at Establishment Labs Holdings Inc (ESTA) After 7.6% Gain -- GF Value $64.04 vs Price $74.92 - GuruFocus
Establishment Labs Soars as Growth Story Heats Up - TipRanks
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture - Finansavisen
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture - TradingView
Establishment (ESTA) Latest Quarter: EPS Clears the Reported Estimate in the Latest Session; Shares Finish 0.35% Up - vinanet.vn
Establishment Labs Holdings Inc (ESTA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Finanzdaten der Establishment Labs Holdings Inc-Aktie (ESTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Establishment Labs Holdings Inc-Aktie (ESTA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| JW Asset Management, LLC | May 28 '26 |
Sale |
72.89 |
65,100 |
4,745,139 |
2,890,582 |
|
| JW Asset Management, LLC | May 27 '26 |
Sale |
72.50 |
113 |
8,192 |
2,955,682 |
|
| JW Asset Management, LLC | May 26 '26 |
Sale |
74.39 |
25,320 |
1,883,555 |
2,955,795 |
|
| JW Asset Management, LLC | 10% Owner |
May 21 '26 |
Sale |
71.40 |
16,999 |
1,213,729 |
2,981,115 |
| JW Asset Management, LLC | 10% Owner |
May 20 '26 |
Sale |
70.56 |
3,580 |
252,605 |
2,998,114 |
| Chacon Quiros Juan Jose | Director |
May 06 '26 |
Sale |
75.42 |
105,000 |
7,918,872 |
927,504 |
| JW Asset Management, LLC | 10% Owner |
May 06 '26 |
Sale |
75.62 |
60,000 |
4,537,500 |
3,001,694 |
| Chacon Quiros Juan Jose | Director |
May 04 '26 |
Sale |
70.48 |
7,751 |
546,308 |
1,032,504 |
| Chacon Quiros Juan Jose | Director |
May 01 '26 |
Sale |
70.78 |
67,249 |
4,759,569 |
1,040,255 |
| Chacon Quiros Juan Jose | Director |
Apr 27 '26 |
Sale |
66.26 |
2,180 |
144,439 |
1,107,504 |
0.29%
3.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):